History of St. Joseph Mercy Ann Arbor Cancer Center
St. Joseph Mercy Ann Arbor Cancer Center in Michigan offers state of the art cancer care to their patients. The teaching hospital was founded in 1911 by four Sisters of Mercy and began with a staff of only nine care providers. Since then the hospital, and cancer center within, has been named a Top 100 Hospital and provides patients with a multidisciplinary approach to cancer care, enabling the most positive outcomes.
St. Joseph Mercy Ann Arbor Cancer Center makes the most of a patient’s time and schedules visits with multiple cancer specialists at one time, which can expedite the creation of a treatment plan.
Not only can patients receive personalized care at the St. Joseph Mercy Ann Arbor Cancer Center but partnerships with neighboring centers creates a multitude of patient options. For instance, the most cutting-edge clinical trials may be added to the standard treatment modalities through the cancer centers partnership with the Mayo Clinic.
St. Joseph Mercy Ann Arbor Cancer Center Specializations
- Clinical Trials
- Cyberknife Radiosurgery
- da Vinci Robotic Surgery
- Medical Oncology
- Radiation Oncology
- Thoracic Malignancies
St. Joseph Mercy Ann Arbor Cancer Center Accreditations
- Joint Commission on Accreditation of Healthcare Organizations
- American College of Surgeons Commission on Cancer Approved Program with Commendation
- Blue Cross Blue Shield of Michigan Oncology Care Program
- Designated by the National Cancer Institute as a Clinical Community Oncology Program (CCOP)
04. Mesothelioma Clinical Trials
Mesothelioma Clinical Trials at St. Joseph Mercy Ann Arbor Cancer Center
The following clinical trials are in progress or actively recruiting participants at St. Joseph Mercy Ann Arbor Cancer Center:
Conditions: Carcinoma, Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Nasopharyngeal Carcinoma, Cholangiocarcinoma, Carcinoma, Basal Cell, Gastrointestinal Stromal Tumors, Carcinoid Tumor, Carcinoma, Transitional Cell, Carcinoma, Adenoid Cystic, Teratoma, Adenocarcinoma of Lung, Carcinoma, Neuroendocrine, Pheochromocytoma, Seminoma, Choriocarcinoma, Cystadenocarcinoma, Serous, Cystadenocarcinoma, Carcinoma, Endometrioid, Paraganglioma, Chordoma, Hemangiosarcoma, Fibromatosis, Aggressive, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, Trophoblastic Neoplasms, Gestational Trophoblastic Disease, Nerve Sheath Neoplasms, Neurofibrosarcoma, Thyroid Neoplasms, Fibroma, Cystadenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Vulvar Neoplasms, Sex Cord-Gonadal Stromal Tumors, Adrenocortical Carcinoma, Carcinoma, Islet Cell, Paget Disease, Extramammary, Adenocarcinoma, Papillary, Carcinoma, Acinar Cell, Adenocarcinoma, Bronchiolo-Alveolar, Mixed Tumor, Mullerian, Neoplasms, Unknown Primary, Carcinoma, Giant Cell
Last Updated: April 3, 2021